Project Grant R21AA031560
Award Date
8/22/24
Completion Date
7/31/26
Dollars Obligated
$213K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Maywood, IL 60153, USA
Similar Awards
The University of California, San Diego (UCSD) was awarded a $414,750 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to investigate the role of intestinal gp130 signaling in preventing alcohol-associated liver disease. The proposed research aims to define the gp130-STAT3-Reg3 signaling axis involved in protecting against ethanol-induced liver disease and assess the potential of a novel engineered gp130...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) funds research to investigate the role of the gut microbiota in alcohol seeking and reward-related decision-making. The $510,412.27 award to the University of Maryland, Baltimore aims to use mouse models and computational modeling to determine whether prebiotics, which alter the gut microbiome, can ameliorate alcohol-induced impairments in these...
This $349,738 project grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) is funding research at Ursinus College to investigate the role of microglial fractalkine signaling in altered dopaminergic wiring resulting from fetal alcohol spectrum disorders (FASD). The research aims to (1) define the developmental timing of alcohol-induced alterations in fractalkine signaling, and (2) determine the impact of these changes on...
This Project Grant award in the amount of $404,508.00 was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award aims to examine interleukin-1β (IL-1β) synaptic regulation and its role in cognitive impairment during early withdrawal and protracted abstinence from chronic alcohol exposure in male and female mice. The overarching goal is to determine the neuroimmune mechanisms by which chronic...
The University of California Irvine was awarded a $412,125 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The grant funds a research project to comprehensively determine how alcohol consumption alters the metabolism of critical organs, which can contribute to alcohol-induced organ damage. The project will employ arteriovenous metabolomics to quantitatively measure the dynamic metabolic...
This $214,385 Project Grant, awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support the development and characterization of a novel in vivo model called CHIMERA-BONCAT. This model will enable comprehensive, unbiased, and cell-type-specific proteomic analysis of the human microglial response to alcohol exposure in an in vivo environment. The research aims to: 1) Characterize the reactivity...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will fund a translational genetic analysis study to identify the genomic architecture of alcohol sensitivity and tolerance in both humans and mice. The $574,808 award, granted on Sep 9, 2024, will support the following key activities: Conducting genome-wide association studies (GWAS) of alcohol sensitivity and tolerance in European...
This $537,587 federal Project Grant award, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), supports research to identify the mechanisms by which the interferon regulatory factor 3 (IRF3) suppresses the expression and secretion of fibroblast growth factor 21 (FGF21) in the liver, and to understand the impact of this regulatory axis on alcohol consumption and alcohol-associated liver disease (ALD). The grant, which...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $223,531 to the University of North Carolina at Chapel Hill (UNC-CH) to develop 3D human neurocircuits to investigate the role of microglia in alcohol use disorder (AUD) and Alzheimer's disease (AD) pathology. The key objectives are to: 1) Determine the impact of alcohol-activated microglia on neuronal metabolism, activity, and survival...
This federal Project Grant award of $131,654, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to develop a Lactobacillus-vectored alkaline phosphatase (AP) therapy to mitigate alcohol-induced leaky gut and reduce lipopolysaccharide (LPS) endotoxin levels. The project has two key objectives: 1) Generate engineered live biotherapeutic products (ELBPs) that can efficiently deliver the...